摘要
抗癌治疗主要取决于达到其指定的细胞和亚细胞靶位点的生物活性能力,同时在非特异位点最大限度地减少积累和副作用。基于纳米技术的药物输送系统能够调整治疗药物的生物分布、组织摄取和的药代动力学,其生物医学的研究和治疗的进展是非常重要的。纳米载体控释制剂可显著提高药物的治疗效果。纳米技术是癌症诊断和治疗中潜在的革新。靶向的纳米药物,无论是销售还是在开发领域,都是被设计用来针对不同类型的癌症。与常规制剂相比,纳米载体能够通过增强癌细胞靶向,减少抗癌药物的细胞毒性作用。新开发的纳米设备,如量子点,脂质体,纳米管,纳米颗粒,微胶粒,金纳米粒子,碳纳米管和固体脂质纳米粒在应用各种癌症治疗上是最有前景的。本综述关注了目前的有关癌症治疗的纳米载体药物的可用的信息和影像。
关键词: 纳米载体,脂质体、癌症治疗、靶向、聚合物纳米颗粒及其临床应用。
图形摘要
Current Drug Targets
Title:Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions
Volume: 17 Issue: 2
Author(s): Rakesh Raj, Pooja Mongia, Suresh Kumar Sahu and Alpana Ram
Affiliation:
关键词: 纳米载体,脂质体、癌症治疗、靶向、聚合物纳米颗粒及其临床应用。
摘要: Anticancer therapies mostly depend on the ability of the bioactives to reach their designated cellular and subcellular target sites, while minimizing accumulation and side effects at non specific sites. The development of nanotechnology based drug delivery systems that are able to modify the biodistribution, tissue uptake and pharmacokinetics of therapeutic agents is considered of great importance in biomedical research and treatment therapy. Controlled releases from nanocarriers can significantly enhance the therapeutic effect of a drug. Nanotechnology has the potential to revolutionize in cancer diagnosis and therapy. Targeted nano medicines either marketed or under development, are designed for the treatment of various types of cancer. Nanocarriers are able to reduce cytotoxic effect of the active anticancer drugs by increasing cancer cell targeting in comparison to conventional formulations. The newly developed nano devices such as quantum dots, liposomes, nanotubes, nanoparticles, micelles, gold nanoparticles, carbon nanotubes and solid lipid nanoparticles are the most promising applications for various cancer treatments. This review is focused on currently available information regarding pharmaceutical nanocarriers for cancer therapy and imaging.
Export Options
About this article
Cite this article as:
Rakesh Raj, Pooja Mongia, Suresh Kumar Sahu and Alpana Ram , Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions, Current Drug Targets 2016; 17 (2) . https://dx.doi.org/10.2174/1389450116666150722141607
DOI https://dx.doi.org/10.2174/1389450116666150722141607 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Phytochemicals to Prevent Inflammation and Allergy
Recent Patents on Inflammation & Allergy Drug Discovery Mechanisms of Resistance to Chemotherapy in Gastric Cancer
Anti-Cancer Agents in Medicinal Chemistry 1,3,4-Thiadiazole Based Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Regulatory T Cells as Targets for Immunotherapy of Autoimmunity and Inflammation
Inflammation & Allergy - Drug Targets (Discontinued) MicroRNA Polymorphisms, MicroRNA Pharmacogenomics and Cancer Susceptibility
Current Pharmacogenomics and Personalized Medicine Transforming Growth Factor β Signaling Perturbation in the Loeys-Dietz Syndrome
Current Medicinal Chemistry A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib
Anti-Cancer Agents in Medicinal Chemistry Role of CD73 in Disease: Promising Prognostic Indicator and Therapeutic Target
Current Medicinal Chemistry Calixarenes in Bio-Medical Researches
Current Medicinal Chemistry Phytoestrogens and Mitochondrial Biogenesis in Breast Cancer. Influence of Estrogen Receptors Ratio
Current Pharmaceutical Design Recent Advances in Structural Studies of the Carbonic Anhydrase Family: The Crystal Structure of Human CA IX and CA XIII
Current Pharmaceutical Design A Facile and Microwave-assisted Rapid Synthesis of 2-Arylamino-4-(3′-indolyl)- thiazoles as Apoptosis Inducing Cytotoxic Agents
Anti-Cancer Agents in Medicinal Chemistry Stem Cells and the Side Population Theory: A Critical Review
Current Tissue Engineering (Discontinued) Stem Cell and Regenerative Medicine
Current Stem Cell Research & Therapy Multifunctional Anti-Cancer Nano-Platforms are Moving to Clinical Trials
Current Drug Metabolism Applications of Molecularly Imprinted Polymers for Isolation of Estrogens from Environmental Water Samples
Current Analytical Chemistry Inflammation and Cancer: When NF-κB Amalgamates the Perilous Partnership
Current Cancer Drug Targets Is Type D Personality Here to Stay? Emerging Evidence Across Cardiovascular Disease Patient Groups
Current Cardiology Reviews The Emerging Role of EMT-related lncRNAs in Therapy Resistance and their Applications as Biomarkers
Current Medicinal Chemistry Anti-cancer Effects of Metformin: Recent Evidences for its Role in Prevention and Treatment of Cancer
Current Drug Metabolism